Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?
Quoin Pharmaceuticals shares surged over 150% on Oct. 10, closing at $20.50 after announcing a $104.5 million private placement with institutional healthcare investors. Intraday, the stock touched $41.80 before retreating. Market cap rose to about $160–170 million. The company, which has no products on the market, is developing QRX003 for Netherton Syndrome and recently secured FDA and EMA orphan drug designations.